Lorenskog, Norway

Lisbeth Johnsen

This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Inven2 as. Active years: 2017-2024.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Lorenskog, NO (2017 - 2019)
  • Finstadjordet, NO (2022 - 2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Lisbeth Johnsen

Introduction

Lisbeth Johnsen is a notable inventor based in Lorenskog, Norway. She has made significant contributions to the field of medical research, particularly in the area of phagocytic activity and neurodegenerative diseases. With a total of 4 patents, her work has the potential to impact the diagnosis and monitoring of various health conditions.

Latest Patents

Lisbeth's latest patents focus on methods and compositions for monitoring phagocytic activity. These inventions relate to diagnosing, monitoring, and assessing the risk of neurodegenerative diseases, such as Alzheimer's disease (AD). Her innovative approaches aim to enhance the understanding and management of diseases associated with phagocytic activity.

Career Highlights

Throughout her career, Lisbeth has worked with prominent organizations, including Inven2 and Akershus Universitetssykehus. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Lisbeth has collaborated with notable colleagues, including Tormod Fladby and Hanne Mali Mollergard. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Lisbeth Johnsen's innovative work in monitoring phagocytic activity and neurodegenerative diseases showcases her dedication to advancing medical research. Her contributions are poised to make a significant difference in the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…